Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

Quantifying heterogeneity in a meta‐analysis

Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763

Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies

Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,602

The 2001 Bethesda System<SUBTITLE>Terminology for Reporting Results of Cervical Cytology</SUBTITLE>

Solomon, D. (2002) · JAMA · doi:10.1001/jama.287.16.2114 · Cited by 3,104

QUANTITATIVE METHODS IN THE REVIEW OF EPIDEMIOLOGIC LITERATURE1

GREENLAND, S. (1987) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036298 · Cited by 1,644

HPV Screening for Cervical Cancer in Rural India

Sankaranarayanan, R., Nene, B. M., Shastri, S. S., Jayant, K., Muwonge, R., Budukh, A. M., Hingmire, S., Malvi, S. G., Thorat, R., Kothari, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808516 · Cited by 1,278

Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer

Mayrand, M., Duarte‐Franco, E., Rodrigues, I., Walter, S. D., Hanley, J. A., Ferenczy, A. S., Ratnam, S., Coutlée, F., & Franco, E. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071430 · Cited by 1,106

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

Ronco, G., Rossi, P. G., Carozzi, F., Confortini, M., Palma, P. D., Mistro, A. D., Ghiringhello, B., Girlando, S., Gillio‐Tos, A., Marco, L. D., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70360-2 · Cited by 955

Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer

Arbyn, M., Ronco, G., Anttila, A., Meijer, C. J. L. M., Poljak, M., Ogilvie, G., Koliopoulos, G., Naucler, P., Sankaranarayanan, R., & Peto, J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.095 · Cited by 897

Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer

Nauclér, P., Ryd, W., Törnberg, S., Strand, A., Wadell, G., Elfgren, K., Rådberg, T., Strander, B., Johansson, B., Forslund, O., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073204 · Cited by 797

European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition—Summary Document

Arbyn, M., Anttila, A., Jordan, J. A., Ronco, G., Schenck, U., Segnan, N., Wiener, H., Herbert, A., & von Karsa, L. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp471 · Cited by 762

Diagnosis of cervical precancerous lesions based on multimodal feature changes

Peng, G., Dong, H., Liang, T., Li, L., & Liu, J. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104209 · Cited by 59

The integrated screening action model (I-SAM): A theory-based approach to inform intervention development

Robb, K. A. (2021) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2021.101427 · Cited by 63

National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study

Smith, M. A., Sherrah, M., Sultana, F., Castle, P. E., Arbyn, M., Gertig, D. M., Caruana, M., Wrede, C. D., Saville, M., & Canfell, K. (2022) · BMJ · doi:10.1136/bmj-2021-068582 · Cited by 59

HPV and Cervical Cancer—Biology, Prevention, and Treatment Updates

Włoszek, E., Krupa, K., Skrok, E., Budzik, M. P., Deptała, A., & Badowska-Kozakiewicz, A. M. (2025) · Current Oncology · doi:10.3390/curroncol32030122 · Cited by 59

Use of Cytology, E6/E7 mRNA, and p16 INK4a –Ki-67 to Define the Management of Human Papillomavirus (HPV)–Positive Women in Cervical Cancer Screening

Gustinucci, D., Rossi, P. G., Cesarini, E. N., Broccolini, M., Bulletti, S., Carlani, A., D’angelo, V., D’amico, M. R., Dato, E. D., Galeazzi, P., et al. (2015) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqv019 · Cited by 61

Cost-Effectiveness of Primary HPV Testing, Cytology and Co-testing as Cervical Cancer Screening for Women Above Age 30 Years

Jin, X. W., Lipold, L. D., Foucher, J. A., Sikon, A. L., Brainard, J., Belinson, J. L., Schramm, S., Nottingham, K. L., Hu, B., & Rothberg, M. B. (2016) · Journal of General Internal Medicine · doi:10.1007/s11606-016-3772-5 · Cited by 60

Eliminating Cervical Cancer: Progress and Challenges for High-income Countries

Davies, J. C., Smith, M. A., Grover, S., Canfell, K., & Crosbie, E. J. (2021) · Clinical Oncology · doi:10.1016/j.clon.2021.06.013 · Cited by 60

HPV prevalence and HPV-related dysplasia in elderly women

Hermansson, R. S., Olovsson, M., Hoxell, E., & Lindström, A. K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0189300 · Cited by 58

Cervical cancer case–control audit: Results from routine evaluation of a nationwide cervical screening program

Wang, J., Elfström, M. K., Andrae, B., Kleppe, S. N., Ploner, A., Lei, J., Dillner, J., Sundström, K., & Sparén, P. (2019) · International Journal of Cancer · doi:10.1002/ijc.32416 · Cited by 58

Barriers and Facilitators to Cervical Cancer Screening Among Women in Rural Ontario, Canada: The Role of Self‐Collected HPV Testing

Racey, C. S., & Gesink, D. (2015) · The Journal of Rural Health · doi:10.1111/jrh.12136 · Cited by 59

Why does cervical cancer occur in a state-of-the-art screening program?

Castle, P. E., Kinney, W., Cheung, L. C., Gage, J. C., Fetterman, B. J., Poitras, N. E., Lorey, T. S., Wentzensen, N., Befano, B., Schussler, J. E., et al. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.06.003 · Cited by 57

Human Papillomavirus Infection Determines Prognosis in Cervical Cancer

Lei, J., Mühr, L. S. A., Lagheden, C., Eklund, C., Kleppe, S. N., Elfström, M., Andrae, B., Sparén, P., Dillner, J., & Sundström, K. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.01930 · Cited by 56

Human Oncogenic Viruses: Characteristics and Prevention Strategies—Lessons Learned from Human Papillomaviruses

Galati, L., Chiantore, M. V., Marinaro, M., & Bonito, P. D. (2024) · Viruses · doi:10.3390/v16030416 · Cited by 56

Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New Zealand

Lew, J., Simms, K. T., Smith, M. A., Lewis, H., Neal, H., & Canfell, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151619 · Cited by 56

Prevalence characteristics of cervical human papillomavirus (HPV) genotypes in the Taizhou area, China: a cross-sectional study of 37 967 women from the general population

Xu, H., Lin, A., Chen, Y. H., Dong, S., Shi, W. W., Yu, J. Z., & Wei Hua, Y. A. N. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014135 · Cited by 55

Cervical screening during the COVID-19 pandemic: optimising recovery strategies

Castañón, A., Rebolj, M., Burger, E. A., de Kok, I. M. C. M., Smith, M. A., Hanley, S. J. B., Carozzi, F. M., Peacock, S. J., & O’Mahony, J. F. (2021) · The Lancet Public Health · doi:10.1016/s2468-2667(21)00078-5 · Cited by 55

Factors influencing cervical cancer screening practice among female health workers in Nigeria: A systematic review

Okolie, E. A., Barker, D., Nnyanzi, L. A., Anjorin, S., Aluga, D., & Nwadike, B. I. (2021) · Cancer Reports · doi:10.1002/cnr2.1514 · Cited by 61

Distribution of human papillomavirus genotypes by severity of cervical lesions in HPV screened positive women from the ESTAMPA study in Latin America

Correa, R. M., Baena, A., Valls, J., Colucci, M. C., Mendoza, L. P., Rol, M., Wiesner, C., Ferrera, A., Fellner, M. D., González, J. V., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272205 · Cited by 58

Cervical Cancer Screening Recommendations: Now and for the Future

Rayner, M., Welp, A. M., Stoler, M. H., & Cantrell, L. A. (2023) · Healthcare · doi:10.3390/healthcare11162273 · Cited by 60

Management of high-risk HPV-positive women for detection of cervical (pre)cancer

Luttmer, R., Strooper, L. M. A. D., Steenbergen, R. D. M., Berkhof, J. H., Snijders, P. J. F., Heideman, D. A. M., & Meijer, C. J. L. M. (2016) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2016.1217157 · Cited by 57

The early detection of cervical cancer. The current and changing landscape of cervical disease detection

Shiraz, A., Crawford, R., Egawa, N., Griffin, H. M., & Doorbar, J. (2020) · Cytopathology · doi:10.1111/cyt.12835 · Cited by 55

Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study

Wang, J., Andrae, B., Sundström, K., Ström, P., Ploner, A., Elfström, K. M., Arnheim‐Dahlström, L., Dillner, J., & Sparén, P. (2016) · BMJ · doi:10.1136/bmj.i276 · Cited by 54

The Possible Effects on Socio-Economic Inequalities of Introducing HPV Testing as Primary Test in Cervical Cancer Screening Programs

Rossi, P. G., Baldacchini, F., & Ronco, G. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00020 · Cited by 55

Direct comparison of two vaginal self-sampling devices for the detection of human papillomavirus infections

Jentschke, M., Chen, K., Arbyn, M., Hertel, B., Noskowicz, M., Soergel, P., & Hillemanns, P. (2016) · Journal of Clinical Virology · doi:10.1016/j.jcv.2016.06.016 · Cited by 54

Management of women with human papillomavirus persistence: long-term follow-up of a randomized clinical trial.

Elfgren, K., Elfström, K. M., Naucler, P., Arnheim-Dahlström, L., & Dillner, J. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.10.042 · Cited by 54

Cervical cancer in Nepal: Current screening strategies and challenges

Narasimhamurthy, M., & Kafle, S. U. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.980899 · Cited by 56

An integrated isothermal nucleic acid amplification test to detect HPV16 and HPV18 DNA in resource-limited settings

Kundrod, K. A., Barra, M., Wilkinson, A. F., Smith, C. A., Natoli, M. E., Chang, M. M., Coole, J. B., Santhanaraj, A., Lorenzoni, C. F., Mavume, C., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abn4768 · Cited by 56

Cervical cancer prevented by screening: Long‐term incidence trends by morphology in N orway

Lönnberg, S., Hansen, B. T., Haldorsen, T., Campbell, S. H., Schee, K., & Nygård, M. (2015) · International Journal of Cancer · doi:10.1002/ijc.29541 · Cited by 55

p16/Ki-67 dual-stained cytology for detecting cervical (pre)cancer in a HPV-positive gynecologic outpatient population

Luttmer, R., Dijkstra, M. G., Snijders, P. J. F., Berkhof, J. H., van Kemenade, F. J., Rozendaal, L., Helmerhorst, T. J. M., Verheijen, R. H. M., ter Harmsel, W. A., van Baal, W. M., et al. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.80 · Cited by 55

Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden

Wang, J., Andrae, B., Sundström, K., Ploner, A., Ström, P., Elfström, K. M., Dillner, J., & Sparén, P. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002414 · Cited by 53

Long-term CIN3+ risk of HPV positive women after triage with FAM19A4/miR124-2 methylation analysis

Dick, S., Kremer, W. W., Strooper, L. M. A. D., Lissenberg-Witte, B. I., Steenbergen, R. D. M., Meijer, C. J. L. M., Berkhof, J. H., & Heideman, D. A. M. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2019.06.002 · Cited by 55

HPV negative cervical cancers and primary HPV screening.

Tjalma, W. (2018) · PubMed Central · Cited by 53

MSCI: A multistate dataset for colposcopy image classification of cervical cancer screening

Yu, Y., Ma, J., Zhao, W., Li, Z., & Ding, S. (2020) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2020.104352 · Cited by 54

The psychosexual impact of testing positive for high‐risk cervical human papillomavirus (HPV): A systematic review

Bennett, K. F., Waller, J., Ryan, M., Bailey, J., & Marlow, L. A. V. (2019) · Psycho-Oncology · doi:10.1002/pon.5198 · Cited by 52

Screening technologies for cervical cancer: Overview

Banerjee, D., Mittal, S., Mandal, R., & Basu, P. S. (2022) · CytoJournal · doi:10.25259/cmas_03_04_2021 · Cited by 54

Avaliação das ações de controle do câncer de colo do útero no Brasil e regiões a partir dos dados registrados no Sistema Único de Saúde

Silva, G. A. E., Alcântara, L. L. D. M., Tomazelli, J. G., Ribeiro, C. M., Girianelli, V. R., Santos, É. C. D. A., Claro, I. B., de Almeida, P. F., & de Lima, L. D. (2022) · Cadernos de Saúde Pública · doi:10.1590/0102-311xpt041722 · Cited by 52

Comparison of urine and cervical samples for detecting human papillomavirus (HPV) with the Cobas 4800 HPV test

Bernal, S., Palomares, J. C., Artura, A., Parra, M., Cabezas, J. L., Robles, A., & Martín‐Mazuelos, E. (2014) · Journal of Clinical Virology · doi:10.1016/j.jcv.2014.10.001 · Cited by 52

Human papillomavirus genotype and viral load agreement between paired first-void urine and clinician-collected cervical samples

Keer, S. V., Tjalma, W. A. A., Pattyn, J., Biesmans, S., Pieters, Z., Ostade, X. V., Ieven, M. M., Damme, P. V., & Vorsters, A. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3179-1 · Cited by 53

Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytology

Stoler, M. H., Wright, T. C., Parvu, V., Yanson, K. A., Cooper, C. K., & Andrews, J. C. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.12.024 · Cited by 53

Acceptability of self‐taken vaginal HPV sample for cervical screening among an under‐screened Indigenous population

Adcock, A., Cram, F., LAWTON, B. A., GELLER, S. E., Hibma, M. H., Sykes, P. H., MacDonald, E. J., Dallas-Katoa, W., Rendle, B., Cornell, T., et al. (2019) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12933 · Cited by 61

Contributions of Liquid-Based (Papanicolaou) Cytology and Human Papillomavirus Testing in Cotesting for Detection of Cervical Cancer and Precancer in the United States

Kaufman, H. W., Alagia, D. P., Chen, Z., Oniśko, A., & Austin, R. M. (2020) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaa074 · Cited by 52

Analytical and clinical performance of extended HPV genotyping with BD Onclarity HPV Assay in home-collected first-void urine: A diagnostic test accuracy study

Keer, S. V., Latsuzbaia, A., Broeck, D. V., Sutter, P. D., Donders, G. G. G., Doyen, J., Tjalma, W. A. A., Weyers, S., Arbyn, M., & Vorsters, A. (2022) · Journal of Clinical Virology · doi:10.1016/j.jcv.2022.105271 · Cited by 51

Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial

Cook, D. A., Mei, W., Smith, L., van Niekerk, D. J., Ceballos, K. M., Franco, E. L., Coldman, A. J., Ogilvie, G. S., & Krajden, M. (2015) · BMC Cancer · doi:10.1186/s12885-015-1959-5 · Cited by 51

CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell

Song, Q., Yi, F., Zhang, Y., Li, D. K. J., Wei, Y., Yu, H., & Zhang, Y. (2019) · BMC Cancer · doi:10.1186/s12885-019-5671-8 · Cited by 50

Human Papillomavirus: Challenges and Opportunities for the Control of Cervical Cancer

Piña‐Sánchez, P. (2022) · Archives of Medical Research · doi:10.1016/j.arcmed.2022.11.009 · Cited by 53

Recent trends in cervical cancer incidence, stage at diagnosis, and mortality according to county‐level income in the United States, 2000–2019

Amboree, T. L., Damgacioglu, H., Sonawane, K., Adsul, P., Montealegre, J. R., & Deshmukh, A. A. (2024) · International Journal of Cancer · doi:10.1002/ijc.34860 · Cited by 50

Effectiveness of novel, lower cost molecular human papillomavirus‐based tests for cervical cancer screening in rural china

Valdez, M., Jerónimo, J., Bansil, P., Qiao, Y., Zhao, F., Chen, W., Zhang, X., Kang, L., Paul, P., Bai, P., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29877 · Cited by 52

Performance and Diagnostic Accuracy of a Urine-Based Human Papillomavirus Assay in a Referral Population

Cuzick, J. M., Cadman, L., Ahmad, A. S., Ho, L., Terry, G., Kleeman, M., Lyons, D., Austin, J., Stoler, M. H., Vibat, C. R. T., et al. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0960 · Cited by 51

Prevalence of human papillomavirus genotypes and relative risk of cervical cancer in China: a systematic review and meta-analysis

Xu, H., Wang, K., Feng, X., Dong, S., Lin, A., Zheng, L., & Yan, W. (2018) · Oncotarget · doi:10.18632/oncotarget.24169 · Cited by 50

Reaching under‐screened/never‐screened indigenous peoples with human papilloma virus self‐testing: A community‐based cluster randomised controlled trial

MacDonald, E. J., GELLER, S. E., Sibanda, N., Stevenson, K., Denmead, L., Adcock, A., Cram, F., Hibma, M. H., Sykes, P. H., & LAWTON, B. A. (2020) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.13285 · Cited by 51

Age-related distribution of uncommon HPV genotypes in cervical intraepithelial neoplasia grade 3

Giannella, L., Rossi, P. G., Carpini, G. D., Giuseppe, J. D., Bogani, G., Gardella, B., Monti, E., Liverani, C. A., Ghelardi, A., Insinga, S., et al. (2021) · Gynecologic Oncology · doi:10.1016/j.ygyno.2021.03.025 · Cited by 50

Real-world effectiveness of primary screening with high-risk human papillomavirus testing in the cervical cancer screening programme in China: a nationwide, population-based study

Zhao, Y., Bao, H., Ma, L., Song, B., Di, J., Wang, L., Gao, Y., Ren, W., Shi, W., Wang, H., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-02026-0 · Cited by 51

Extension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot data

Rebolj, M., Cuschieri, K. S., Mathews, C. S., Pesola, F., Denton, K. J., & Kitchener, H. C. (2022) · BMJ · doi:10.1136/bmj-2021-068776 · Cited by 49

A portable all-in-one microfluidic device with real-time colorimetric LAMP for HPV16 and HPV18 DNA point-of-care testing

Bai, H., Liu, Y., Gao, L., Wang, T., Zhang, X., Hu, J., Ding, L., Zhang, Y., Wang, Q., Wang, Q., et al. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115968 · Cited by 49

Correlates of women’s intentions to be screened for human papillomavirus for cervical cancer screening with an extended interval

Ogilvie, G. S., Smith, L., van Niekerk, D., Khurshed, F., Pedersen, H., Taylor, D., Thomson, K. A., Greene, S. B., Babich, S. M., Franco, E. L., et al. (2016) · BMC Public Health · doi:10.1186/s12889-016-2865-8 · Cited by 49

Impact of variations in triage cytology interpretation on human papillomavirus–based cervical screening and implications for screening algorithms

Ronco, G., Zappa, M., Franceschi, S., Tùnesi, S., Caprioglio, A., Confortini, M., Mistro, A. D., Carozzi, F., Segnan, N., Zorzi, M., et al. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.09.008 · Cited by 49

Prognostic role of vascular endothelial growth factor in cervical cancer: a meta-analysis

Zhang, J., Liu, J., Zhu, C., He, J., Chen, J., Liang, Y., Yang, F., Wu, X. Y., & Ma, X. (2017) · Oncotarget · doi:10.18632/oncotarget.15044 · Cited by 49

Uptake and acceptability of human papillomavirus self-sampling in rural and remote aboriginal communities: evaluation of a nurse-led community engagement model

Dutton, T., Marjoram, J., Burgess, S., Montgomery, L., Vail, A., Callan, N., Jacob, S., Hawkes, D. J., Saville, M., & Bailey, J. (2020) · BMC Health Services Research · doi:10.1186/s12913-020-05214-5 · Cited by 49

Comparative accuracy of cervical cancer screening strategies in healthy asymptomatic women: a systematic review and network meta-analysis

Terasawa, T., Hosono, S., Sasaki, S., Hoshi, K., Hamashima, Y., Katayama, T., & Hamashima, C. (2022) · Scientific Reports · doi:10.1038/s41598-021-04201-y · Cited by 51

Cervical Cancer Prevention

Thaxton, L. D., & Waxman, A. G. (2015) · Medical Clinics of North America · doi:10.1016/j.mcna.2015.01.003 · Cited by 49

HPV-positive women with normal cytology remain at increased risk of CIN3 after a negative repeat HPV test

Polman, N. J., Veldhuijzen, N. J., Heideman, D. A. M., Snijders, P. J. F., Meijer, C. J. L. M., & Berkhof, J. H. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.309 · Cited by 48

HPV-negative Tumors in a Swedish Cohort of Cervical Cancer

Kaliff, M., Karlsson, M. G., Sorbe, B., Mordhorst, L. B., Helenius, G., & Larsson, G. L. (2019) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0000000000000612 · Cited by 49

Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study

Aarnio, R., Östensson, E., Olovsson, M., Gustavsson, I. M., & Gyllensten, U. B. (2020) · BMC Cancer · doi:10.1186/s12885-020-07085-9 · Cited by 48

Performance of a new HPV and biomarker assay in the management of hrHPV positive women: Subanalysis of the ongoing multicenter TRACE clinical trial (n > 6,000) to evaluate POU4F3 methylation as a potential biomarker of cervical precancer and cancer

Kocsis, A., Takács, T., Jeney, C., Schaff, Z., Koiss, R., Járay, B., Sobel, G., Pap, K., Székely, I., Ferenci, T., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30534 · Cited by 47

Differential HPV16 variant distribution in squamous cell carcinoma, adenocarcinoma and adenosquamous cell carcinoma

Nicolás-Párraga, S., Alemany, L., de Sanjosé, S., Bosch, F. X., Bravo, I. G., & groups, O. B. O. T. R. H. T. A. H. V. S. (2017) · International Journal of Cancer · doi:10.1002/ijc.30636 · Cited by 48

Concordant testing results between various human papillomavirus assays in primary cervical cancer screening: systematic review

de Thurah, L., Bonde, J. H., Lam, J. U. H., & Rebolj, M. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.05.020 · Cited by 49

Self-sampling coupled to the detection of HPV 16 and 18 E6 protein: A promising option for detection of cervical malignancies in remote areas

Torres, K. L., Mariño, J. M., Rocha, D. A. P., de Mello, M. B., Farah, H. H. D. M., Reis, R. D. S., Alves, V. D. C. R., Gomes, E., Martins, T. R., Soares, A. C., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201262 · Cited by 47

Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotyping

FRIDA Study Group, Hernández‐López, R., Lörincz, A. T., Torres‐Ibarra, L., Reuter, C., Scibior‐Bentkowska, D., Warman, R., Nedjai, B., Mendiola-Pastrana, I. R., León-Maldonado, L. S., et al. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0743-9 · Cited by 50

Laser-assisted rapid evaporative ionisation mass spectrometry (LA-REIMS) as a metabolomics platform in cervical cancer screening

Paraskevaidi, M., Cameron, S. J. S., Whelan, E., Bowden, S. J., Tzafetas, M., Mitra, A., Semertzidou, A., Athanasiou, A., Bennett, P. R., MacIntyre, D. A., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103017 · Cited by 47

Urine HPV in the Context of Genital and Cervical Cancer Screening—An Update of Current Literature

Daponte, A. I., Michail, G., Daponte, A., Daponte, A., & Valasoulis, G. (2021) · Cancers · doi:10.3390/cancers13071640 · Cited by 47

Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above

Rebolj, M., Bonde, J. H., Preisler, S., Ejegod, D. M., Rygaard, C., & Lynge, E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147326 · Cited by 46

Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua

Campos, N. G., Mvundura, M., Jerónimo, J., Holme, F., Vodicka, E. L., & Kim, J. J. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015048 · Cited by 46

Long non-coding RNA CRNDE enhances cervical cancer progression by suppressing PUMA expression

Zhang, J., & Fan, L. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108726 · Cited by 46

Strategies to eliminate cervical cancer in China

Ji, L., Chen, M., & Yao, L. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1105468 · Cited by 46

Aptima HPV Assay versus Hybrid Capture® 2 HPV test for primary cervical cancer screening in the HPV FOCAL trial

Cook, D. A., Smith, L., Law, J. H., Mei, W., van Niekerk, D. J., Ceballos, K. M., Gondara, L., Franco, E. L., Coldman, A. J., Ogilvie, G. S., et al. (2016) · Journal of Clinical Virology · doi:10.1016/j.jcv.2016.12.004 · Cited by 45

First-void urine: A potential biomarker source for triage of high-risk human papillomavirus infected women

Keer, S. V., Pattyn, J., Tjalma, W. A. A., Ostade, X. V., Ieven, M. M., Damme, P. V., & Vorsters, A. (2017) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2017.06.036 · Cited by 47

Approaches to triage optimization in HPV primary screening: Extended genotyping and p16/Ki‐67 dual‐stained cytology—Retrospective insights from ATHENA

Stoler, M. H., Baker, E., Boyle, S., Aslam, S., Ridder, R., Huh, W. K., & Wright, T. C. (2019) · International Journal of Cancer · doi:10.1002/ijc.32669 · Cited by 48

Cervical Cancer Screening Guidelines in the Postvaccination Era: Review of the Literature

Liverani, C. A., Giuseppe, J. D., Giannella, L., Carpini, G. D., & Ciavattini, A. (2020) · Journal of Oncology · doi:10.1155/2020/8887672 · Cited by 45

Is the HPV-test more cost-effective than cytology in cervical cancer screening? An economic analysis from a middle-income country

Vale, D. B., Silva, M. T., Discacciati, M. G., Polegatto, I., Teixeira, J. C., & Zeferino, L. C. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251688 · Cited by 46

Performance of HPV E6 / E7 mRNA assay as primary screening test: Results from the NTCC2 trial

Rossi, P. G., Ronco, G., Mancuso, P., Carozzi, F., Allìa, E., Bisanzi, S., Gillio‐Tos, A., Marco, L. D., Rizzolo, R., Gustinucci, D., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.34120 · Cited by 45

Is HPV DNA testing specificity comparable to that of cytological testing in primary cervical cancer screening? Results of a meta‐analysis of randomized controlled trials

Pileggi, C., Flotta, D., Bianco, A., Nobile, C. G. A., & Pavía, M. (2013) · International Journal of Cancer · doi:10.1002/ijc.28640 · Cited by 45

Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4/miR124-2 methylation and HPV genotyping

Dick, S., Vink, F. J., Heideman, D. A. M., Lissenberg-Witte, B. I., Meijer, C. J. L. M., & Berkhof, J. H. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01614-4 · Cited by 44

Entangled Connections: HIV and HPV Interplay in Cervical Cancer—A Comprehensive Review

Pavone, G., Marıno, A., Fisicaro, V., Motta, L., Spata, A., Martorana, F., Spampinato, S., Celesia, B. M., Cacopardo, B. S., Vigneri, P. G., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910358 · Cited by 44

Major clinical research advances in gynecologic cancer in 2013

Suh, D. H., Kim, J., Kang, S., Kim, H. J., & Lee, K.-H. (2014) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2014.25.3.236 · Cited by 45

The Clinical and Economic Benefits of Co-Testing Versus Primary HPV Testing for Cervical Cancer Screening: A Modeling Analysis

Felix, J. C., Lacey, M. J., Miller, J. D., Lenhart, G. M., Spitzer, M., & Kulkarni, R. (2016) · Journal of Women s Health · doi:10.1089/jwh.2015.5708 · Cited by 44

HPV primary cervical screening in England: Women's awareness and attitudes

Patel, H., Moss, E. L., & Sherman, S. M. (2018) · Psycho-Oncology · doi:10.1002/pon.4694 · Cited by 44

Computer-Aided Diagnosis of Label-Free 3-D Optical Coherence Microscopy Images of Human Cervical Tissue

Ma, Y., Xu, T., Huang, X., Wang, X., Li, C., Jerwick, J., Yuan, N., Zeng, X., Wang, B., Wang, Y., et al. (2019) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2018.2890167 · Cited by 45

The Valgent4 protocol: Robust analytical and clinical validation of 11 HPV assays with genotyping on cervical samples collected in SurePath medium.

Bonde, J., Ejegod, D. M., Cuschieri, K., Dillner, J., Heideman, D. A. M., Quint, W., Pavon Ribas, M. A., Padalko, E., Christiansen, I. K., Xu, L., et al. (2018) · Journal of Clinical Virology · doi:10.1016/j.jcv.2018.09.012 · Cited by 44

Influence of Spirituality and Modesty on Acceptance of Self-Sampling for Cervical Cancer Screening

Dareng, E., Jedy-Agba, E. E., Bamisaye, P., Modibbo, F. I., Oyeneyin, L. O., Adewole, A., Olaniyan, O., Dakum, P., Pharoah, P. D. P., & Adebamowo, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141679 · Cited by 43

Cervical Carcinoma in the European Union An Update on Disease Burden, Screening Program State of Activation, and Coverage as of March 2014

Altobelli, E., & Lattanzi, A. (2015) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000374 · Cited by 43

Performance of careHPV for detecting high-grade cervical intraepithelial neoplasia among women living with HIV-1 in Burkina Faso and South Africa: HARP study

for the HARP Study Group, Segondy, M., Kelly, H. A., Mahlangu, M. P., Djigma, F. W., Ngou, J., Gilham, C., Omar, T., Goumbri-Lompo, O., Michelow, P. M., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.207 · Cited by 45

Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an example: A modelled analysis

Smith, M. A., Burger, E. A., Castañón, A., de Kok, I. M. C. M., Hanley, S. J. B., Rebolj, M., Hall, M. T., Jansen, E. E. L., Killen, J., O'Farrell, X., et al. (2021) · Preventive Medicine · doi:10.1016/j.ypmed.2021.106623 · Cited by 43

COVID-19 disruption to cervical cancer screening in England

Castañón, A., Rebolj, M., Pesola, F., Pearmain, P., & Stubbs, R. (2022) · Journal of Medical Screening · doi:10.1177/09691413221090892 · Cited by 43

Cancer prevention: state of the art and future prospects

Valle, I., Tramalloni, D., & Bragazzi, N. L. (2015) · Journal of preventive medicine and hygiene · doi:10.15167/2421-4248/jpmh2015.56.1.471 · Cited by 43

Comparison of urine, self-collected vaginal swab, and cervical swab samples for detecting human papillomavirus (HPV) with Roche Cobas HPV, Anyplex II HPV, and RealTime HR-S HPV assay

Cho, H.-W., Ouh, Y.-T., Hong, J. H., Min, K. J., So, K. A., Kim, T. J., Paik, E. S., Lee, J., Moon, J. H., & Lee, J. K. (2019) · Journal of Virological Methods · doi:10.1016/j.jviromet.2019.04.012 · Cited by 42

Trends in cervical cancer and its precursor forms to evaluate screening policies in a mid-sized Northeastern Brazilian city

Lima, M. S., Brito, É. D. A. C., Siqueira, H. F. F., Santos, M. D. O., da Silva, Â. M., Nunes, M. A. P., Brito, H. L. D. F., Lima, M. M. M., Cipolotti, R., & Lima, C. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233354 · Cited by 42

Randomised study shows that repeated self-sampling and HPV test has more than two-fold higher detection rate of women with CIN2+ histology than Pap smear cytology

Gustavsson, I. M., Aarnio, R., Berggrund, M., Hedlund‐Lindberg, J., Strand, A.-S., Sanner, K., Wikström, I., Enroth, S., Olovsson, M., & Gyllensten, U. B. (2018) · British Journal of Cancer · doi:10.1038/bjc.2017.485 · Cited by 42

Enhanced Detection of Cervical Cancer and Precancer Through Use of Imaged Liquid-Based Cytology in Routine Cytology and HPV Cotesting

Austin, R. M., Oniśko, A., & Zhao, C. (2018) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqy114 · Cited by 42

Organization of cervical cancer screening with DNA–HPV testing impact on early–stage cancer detection: a population–based demonstration study in a Brazilian city

Teixeira, J. C., Vale, D. B., Campos, C. S., Bragança, J. F., Discacciati, M. G., & Zeferino, L. C. (2021) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2021.100084 · Cited by 42

Barriers to and Facilitators of Compliance with Clinic-Based Cervical Cancer Screening: Population-Based Cohort Study of Women Aged 23-60 Years

Östensson, E., Alder, S., Elfström, K. M., Sundström, K., Zethraeus, N., Arbyn, M., & Andersson, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128270 · Cited by 44

Efficacy of HPV-Based Screening for Prevention of Invasive Cervical Cancer

Ronco, G., Dillner, J., Elfström, K. M., Tùnesi, S., Snijders, P. J. F., Arbyn, M., Kitchener, H. C., Segnan, N., Gilham, C., Rossi, P. G., et al. (2014) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000453824.69728.c0 · Cited by 6

Embracing a new era in cervical cancer screening

Isidean, S. D., & Franco, E. L. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62028-0 · Cited by 18

Human papillomavirus-based cervical screening and long-term cervical cancer risk: a randomised health-care policy trial in Sweden

Wang, J., Elfström, K. M., & Dillner, J. (2024) · The Lancet Public Health · doi:10.1016/s2468-2667(24)00218-4 · Cited by 63

Evaluation of primary HPV-based cervical screening among older women: Long-term follow-up of a randomized healthcare policy trial in Sweden

Yao, Q. Y., Wang, J., Elfström, M. K., Strander, B., Dillner, J., & Sundström, K. (2024) · PLoS Medicine · doi:10.1371/journal.pmed.1004505 · Cited by 6

HPV screening offers greater protection against invasive cervical cancer than cytology, finds analysis

Kmietowicz, Z. (2013) · BMJ · doi:10.1136/bmj.f6624